France · Source-listed medicine information

France / CIS 68655884

CONTRAMAL 50 mg, gélule

gélule · orale

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formgélule
Routeorale
Ingredient entries1
CountryFrance

Product identity

At a glance

Authorisation holder
LABORATOIRES GRUNENTHAL
Authorisation status
Autorisation active
Market status
Commercialisée
Country
France
Source reference
CIS 68655884

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for CONTRAMAL 50 mg, gélule
IngredientStrength / referenceSource role
CHLORHYDRATE DE TRAMADOLgélule50 mgune géluleSAGroup 1

Pack references

Presentations (6)

plaquette(s) thermoformée(s) PVC aluminium de 30 gélule(s)

CIP13 3400930002285

Présentation active · Déclaration d'arrêt de commercialisation
10 plaquette(s) thermoformée(s) PVC-Aluminium PVDC polyéthylène de 1 gélule(s)

CIP13 3400930265215

Présentation active · Déclaration de commercialisation
plaquette(s) thermoformée(s) PVC-Aluminium PVDC polyéthylène de 30 gélule(s)

CIP13 3400930297452

Présentation active · Déclaration d'arrêt de commercialisation
30 plaquette(s) thermoformée(s) PVC-Aluminium PVDC polyéthylène de 1 gélule(s)

CIP13 3400934808166

Présentation active · Déclaration de commercialisation
plaquette(s) thermoformée(s) PVC aluminium de 100 gélule(s)

CIP13 3400955000945

Présentation active · Déclaration d'arrêt de commercialisation
100 plaquette(s) thermoformée(s) PVC-Aluminium PVDC polyéthylène de 1 gélule(s)

CIP13 3400956111220

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 68655884 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source fileRetrievedSource file modified
fr_products.txtNot supplied
fr_composition.txtNot supplied
fr_packs.txtNot supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →